There is no published information on the causes of bacteremia in the Lao PDR (Laos). Between 2000 and 2004, 4512 blood culture pairs were taken from patients admitted to Mahosot Hospital, Vientiane, Laos, with suspected community-acquired bacteremia; 483 (10.7%) cultures grew a clinically significant community-acquired organism, most commonly Salmonella enterica serovar typhi (50.9%), Staphylococcus aureus (19.0%), and Escherichia coli (12.4%). S. aureus bacteremia was common among infants (69.2%), while children 1-5 years had a high frequency of typhoid (44%). Multi-drug-resistant S. Typhi was rare (6%). On multiple logistic regression analysis, typhoid was associated with younger age, longer illness, diarrhea, higher admission temperature, and lower peripheral white blood cell count than non-typhoidal bacteremia. Empirical parenteral ampicillin and gentamicin would have some activity against approximately 88% of clinically significant isolates at a cost of US $1.4/day, an important exception being B. pseudomallei. Bacteremic infants in this setting require an anti-staphylococcal antibiotic.
The diagnostic utility of immunochromatographic (Leptotek) and enzyme-linked immunosorbent assay (ELISA; Panbio) tests for the detection of Leptospira immunoglobulin M antibodies was assessed in febrile adults admitted in Vientiane, Laos. Both tests demonstrated poor diagnostic accuracy using admission serum (Leptotek sensitivity of 47.3% and specificity of 75.5%: ELISA sensitivity of 60.9% and specificity of 65.6%) compared to the Leptospira "gold standard" microscopic agglutination test.The laboratory diagnosis of acute Leptospira infection is usually dependent on serological methods. The "gold standard" microscopic agglutination test (MAT) requires paired specimens and considerable technical resources and training and is therefore not useful for acute patient management (5). Rapid methods, such as lateral flow immunochromatographic tests (ICT) and enzyme-linked immunosorbent assay (ELISA) formats that detect leptospiral immunoglobulin M (IgM) antibodies have demonstrated high diagnostic accuracy (1,4,8,10,11). However, a recent study in Viet Nam suggested a poor diagnostic utility of such tests there (9). Here we report the diagnostic accuracy of a commercial ELISA and an ICT for the detection of Leptospira IgM antibodies among adults with fever in the Lao People's Democratic Republic (Laos), where leptospirosis is endemic.Human sera were collected after informed oral consent was obtained as part of a study to determine the causes of unexplained fever for patients presenting at Mahosot Hospital, Vientiane, Laos, between November 2001 and October 2003 (7). Paired admission and convalescent-phase serum specimens were available from 186 patients (total sample, n ϭ 372) and stored at Ϫ85°C until tested. Unpaired sera were not included. Ethical approval was granted by the Ethical Review Committee of the Faculty of Medical Sciences, National University of Laos, Vientiane, Laos.A commercial ELISA (Panbio Pty, Ltd., Australia) for the detection of IgM antibodies against Leptospira species was performed according to the manufacturer's instructions. The results were calculated as "Panbio units" with results of Յ9.0, 9.0 to 11.0, and Ն11.0 defined as negative, equivocal, and positive, respectively. Samples that initially returned an equivocal result were retested. An ICT (Leptotek; Organon-Teknika, The Netherlands) for the detection of Leptospira IgM antibodies was performed according to the manufacturer's instructions. All results were read by eye by the same operator and recorded as positive, equivocal, or negative for the presence of specific IgM antibody. The MAT for Leptospira antibodies was performed by reference laboratories in The Netherlands and Australia. Samples 1 to 36 were assessed at WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis, KIT Biomedical Research, Amsterdam, The Netherlands (2). Samples 37 to 186 were assessed at the WHO/ FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis in Australia. A patient was considered to have a current or recent Leptospir...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.